| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.879 | 0 | 0 | 9.319 | 55.639 | 41.631 | 47.106 | 65.959 | 105.616 | 118.348 |
| Total Income - EUR | 1.879 | 0 | 0 | 9.319 | 55.639 | 43.645 | 47.341 | 65.972 | 105.974 | 118.380 |
| Total Expenses - EUR | 8.043 | 0 | 0 | 0 | 2.152 | 6.612 | 14.687 | 21.815 | 44.456 | 53.706 |
| Gross Profit/Loss - EUR | -6.164 | 0 | 0 | 9.319 | 53.487 | 37.033 | 32.654 | 44.157 | 61.517 | 64.674 |
| Net Profit/Loss - EUR | -6.221 | 0 | 0 | 9.040 | 51.818 | 36.518 | 32.183 | 43.497 | 60.461 | 61.195 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Seramed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 1.251 | 70.124 | 67.196 | 112.938 | 94.752 |
| Current Assets | 0 | 0 | 0 | 9.319 | 58.862 | 92.584 | 77.506 | 46.412 | 9.736 | 64.062 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 119 |
| Receivables | 0 | 0 | 0 | 0 | 4.039 | 2.542 | 2.395 | 37.829 | 6.700 | 56.147 |
| Cash | 0 | 0 | 0 | 9.319 | 0 | 90.042 | 75.112 | 8.583 | 3.035 | 7.796 |
| Shareholders Funds | -2.397 | -2.373 | -2.332 | 6.750 | 58.437 | 93.848 | 123.949 | 43.546 | 72.839 | 61.243 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.397 | 2.373 | 2.332 | 2.569 | 424 | 994 | 23.682 | 70.062 | 49.835 | 97.571 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Seramed Srl